2022 annual financial data
Takeda Pharmaceutical 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was 31.47%.
Operating income was 460,844,000,000 JPY and net income was 230,059,000,000 JPY.
Operating cash flow was 1,123,105,000,000 JPY.
Get free Takeda Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,569,006,000,000 JPY
- Operating income
- 460,844,000,000 JPY
- Net income
- 230,059,000,000 JPY
- Operating cash flow
- 1,123,105,000,000 JPY